Home
>
National Drug Code (NDC)
>
Estring
Estring - 0013-2150-36 - (ESTRADIOL)
Drug Information of Estring
| Product NDC: | 0013-2150 |
| Proprietary Name: | Estring |
| Non Proprietary Name: | ESTRADIOL |
| Active Ingredient(s): | 2 mg/1 & nbsp; ESTRADIOL |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | RING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Estring
| Product NDC: | 0013-2150 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020472 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960426 |
Package Information of Estring
| Package NDC: | 0013-2150-36 |
| Package Description: | 1 POUCH in 1 CARTON (0013-2150-36) > 1 RING in 1 POUCH |
NDC Information of Estring
| NDC Code | 0013-2150-36 |
| Proprietary Name | Estring |
| Package Description | 1 POUCH in 1 CARTON (0013-2150-36) > 1 RING in 1 POUCH |
| Product NDC | 0013-2150 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ESTRADIOL |
| Dosage Form Name | RING |
| Route Name | VAGINAL |
| Start Marketing Date | 19960426 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | ESTRADIOL |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |
